HEADER HYDROLASE/HYDROLASE INHIBITOR 07-MAY-15 4ZPG TITLE BACE1 IN COMPLEX WITH 8-BENZYL-4-(CYCLOHEXYLAMINO)-1-(3-FLUOROPHENYL)- TITLE 2 7-METHYL-1,3,8-TRIAZASPIRO[4.5]DEC-3-EN-2-ONE COMPND MOL_ID: 1; COMPND 2 MOLECULE: BETA-SECRETASE 1; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: ASPARTYL PROTEASE 2,ASP 2,BETA-SITE AMYLOID PRECURSOR COMPND 5 PROTEIN CLEAVING ENZYME 1,BETA-SITE APP CLEAVING ENZYME 1,MEMAPSIN-2, COMPND 6 MEMBRANE-ASSOCIATED ASPARTIC PROTEASE 2; COMPND 7 EC: 3.4.23.46; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BACE1, BACE, KIAA1149; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS ALZHEIMER DISEASE, AMYLOID PRECURSOR PROTEIN SECRETASES, AMYLOID KEYWDS 2 BETA-PEPTIDES, ASPARTIC ACID ENDOPEPTIDASES, BINDING SITES, DRUG KEYWDS 3 DESIGN, MOLECULAR, PROTEASE INHIBITORS, STRUCTURE-ACTIVITY KEYWDS 4 RELATIONSHIP, HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR P.ORTH REVDAT 2 28-OCT-15 4ZPG 1 JRNL REVDAT 1 05-AUG-15 4ZPG 0 JRNL AUTH M.EGBERTSON,G.B.MCGAUGHEY,S.M.PITZENBERGER,S.R.STAUFFER, JRNL AUTH 2 C.A.COBURN,S.J.STACHEL,W.YANG,J.C.BARROW,L.A.NEILSON, JRNL AUTH 3 M.MCWHERTER,D.PERLOW,B.FAHR,S.MUNSHI,T.J.ALLISON,K.HOLLOWAY, JRNL AUTH 4 H.G.SELNICK,Z.YANG,J.SWESTOCK,A.J.SIMON,S.SANKARANARAYANAN, JRNL AUTH 5 D.COLUSSI,K.TUGUSHEVA,M.T.LAI,B.PIETRAK,S.HAUGABOOK,L.JIN, JRNL AUTH 6 I.W.CHEN,M.HOLAHAN,M.STRANIERI-MICHENER,J.J.COOK,J.VACCA, JRNL AUTH 7 S.L.GRAHAM JRNL TITL METHYL-SUBSTITUTION OF AN IMINOHYDANTOIN SPIROPIPERIDINE JRNL TITL 2 BETA-SECRETASE (BACE-1) INHIBITOR HAS A PROFOUND EFFECT ON JRNL TITL 3 ITS POTENCY. JRNL REF BIOORG.MED.CHEM.LETT. V. 25 4812 2015 JRNL REFN ESSN 1464-3405 JRNL PMID 26195137 JRNL DOI 10.1016/J.BMCL.2015.06.082 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER-TNT 2.11.4 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SMART,VONRHEIN,WOMACK, REMARK 3 : MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 27.31 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 34868 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.170 REMARK 3 R VALUE (WORKING SET) : 0.169 REMARK 3 FREE R VALUE : 0.188 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 3.960 REMARK 3 FREE R VALUE TEST SET COUNT : 1382 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 17 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.06 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.75 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2983 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.1821 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2870 REMARK 3 BIN R VALUE (WORKING SET) : 0.1806 REMARK 3 BIN FREE R VALUE : 0.2170 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 3.79 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 113 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2868 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 33 REMARK 3 SOLVENT ATOMS : 277 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 34.64 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 5.22590 REMARK 3 B22 (A**2) : -14.36950 REMARK 3 B33 (A**2) : 9.14360 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.186 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.934 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.936 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2982 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 4062 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 975 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 67 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 443 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2982 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 382 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 3532 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.05 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.84 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 14.41 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4ZPG COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 08-MAY-15. REMARK 100 THE DEPOSITION ID IS D_1000209658. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-MAR-05 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 34982 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 7.100 REMARK 200 R MERGE (I) : 0.08300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.07 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.3 REMARK 200 DATA REDUNDANCY IN SHELL : 7.00 REMARK 200 R MERGE FOR SHELL (I) : 0.55000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 60.44 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.11 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.5M LITHIUM SULFATE, 0.1M HEPES REMARK 280 BUFFER,, PH 7.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 38.53500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 38.53500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 51.91500 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 63.84000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 51.91500 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 63.84000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 38.53500 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 51.91500 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 63.84000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 38.53500 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 51.91500 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 63.84000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 837 LIES ON A SPECIAL POSITION. REMARK 375 HOH A 848 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 429 REMARK 465 LEU A 430 REMARK 465 PRO A 431 REMARK 465 ARG A 432 REMARK 465 GLU A 433 REMARK 465 THR A 434 REMARK 465 ASP A 435 REMARK 465 GLU A 436 REMARK 465 GLU A 437 REMARK 465 PRO A 438 REMARK 465 GLU A 439 REMARK 465 GLU A 440 REMARK 465 PRO A 441 REMARK 465 GLY A 442 REMARK 465 ARG A 443 REMARK 465 ARG A 444 REMARK 465 ALA A 157 REMARK 465 GLY A 158 REMARK 465 PHE A 159 REMARK 465 PRO A 160 REMARK 465 LEU A 161 REMARK 465 ASN A 162 REMARK 465 GLN A 163 REMARK 465 SER A 164 REMARK 465 GLU A 165 REMARK 465 VAL A 166 REMARK 465 LEU A 167 REMARK 465 ALA A 168 REMARK 465 GLU A 310 REMARK 465 ASP A 311 REMARK 465 VAL A 312 REMARK 465 ALA A 313 REMARK 465 THR A 314 REMARK 465 HIS A 360 REMARK 465 VAL A 361 REMARK 465 HIS A 362 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 9 CG CD CE NZ REMARK 470 LYS A 65 CG CD CE NZ REMARK 470 LYS A 142 CE NZ REMARK 470 LYS A 238 CD CE NZ REMARK 470 GLN A 316 CG CD OE1 NE2 REMARK 470 GLU A 364 CG CD OE1 OE2 REMARK 470 PHE A 365 CG CD1 CD2 CE1 CE2 CZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TRP A 197 -84.08 -145.85 REMARK 500 SER A 253 -9.83 -58.43 REMARK 500 ALA A 323 34.00 -96.81 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 4QF A 501 DBREF 4ZPG A 430 385 UNP P56817 BACE1_HUMAN 43 446 SEQADV 4ZPG MET A 429 UNP P56817 INITIATING METHIONINE SEQADV 4ZPG ALA A 75 UNP P56817 LYS 136 CONFLICT SEQADV 4ZPG ALA A 77 UNP P56817 GLU 138 CONFLICT SEQRES 1 A 405 MET LEU PRO ARG GLU THR ASP GLU GLU PRO GLU GLU PRO SEQRES 2 A 405 GLY ARG ARG GLY SER PHE VAL GLU MET VAL ASP ASN LEU SEQRES 3 A 405 ARG GLY LYS SER GLY GLN GLY TYR TYR VAL GLU MET THR SEQRES 4 A 405 VAL GLY SER PRO PRO GLN THR LEU ASN ILE LEU VAL ASP SEQRES 5 A 405 THR GLY SER SER ASN PHE ALA VAL GLY ALA ALA PRO HIS SEQRES 6 A 405 PRO PHE LEU HIS ARG TYR TYR GLN ARG GLN LEU SER SER SEQRES 7 A 405 THR TYR ARG ASP LEU ARG LYS GLY VAL TYR VAL PRO TYR SEQRES 8 A 405 THR GLN GLY ALA TRP ALA GLY GLU LEU GLY THR ASP LEU SEQRES 9 A 405 VAL SER ILE PRO HIS GLY PRO ASN VAL THR VAL ARG ALA SEQRES 10 A 405 ASN ILE ALA ALA ILE THR GLU SER ASP LYS PHE PHE ILE SEQRES 11 A 405 ASN GLY SER ASN TRP GLU GLY ILE LEU GLY LEU ALA TYR SEQRES 12 A 405 ALA GLU ILE ALA ARG PRO ASP ASP SER LEU GLU PRO PHE SEQRES 13 A 405 PHE ASP SER LEU VAL LYS GLN THR HIS VAL PRO ASN LEU SEQRES 14 A 405 PHE SER LEU GLN LEU CYS GLY ALA GLY PHE PRO LEU ASN SEQRES 15 A 405 GLN SER GLU VAL LEU ALA SER VAL GLY GLY SER MET ILE SEQRES 16 A 405 ILE GLY GLY ILE ASP HIS SER LEU TYR THR GLY SER LEU SEQRES 17 A 405 TRP TYR THR PRO ILE ARG ARG GLU TRP TYR TYR GLU VAL SEQRES 18 A 405 ILE ILE VAL ARG VAL GLU ILE ASN GLY GLN ASP LEU LYS SEQRES 19 A 405 MET ASP CYS LYS GLU TYR ASN TYR ASP LYS SER ILE VAL SEQRES 20 A 405 ASP SER GLY THR THR ASN LEU ARG LEU PRO LYS LYS VAL SEQRES 21 A 405 PHE GLU ALA ALA VAL LYS SER ILE LYS ALA ALA SER SER SEQRES 22 A 405 THR GLU LYS PHE PRO ASP GLY PHE TRP LEU GLY GLU GLN SEQRES 23 A 405 LEU VAL CYS TRP GLN ALA GLY THR THR PRO TRP ASN ILE SEQRES 24 A 405 PHE PRO VAL ILE SER LEU TYR LEU MET GLY GLU VAL THR SEQRES 25 A 405 ASN GLN SER PHE ARG ILE THR ILE LEU PRO GLN GLN TYR SEQRES 26 A 405 LEU ARG PRO VAL GLU ASP VAL ALA THR SER GLN ASP ASP SEQRES 27 A 405 CYS TYR LYS PHE ALA ILE SER GLN SER SER THR GLY THR SEQRES 28 A 405 VAL MET GLY ALA VAL ILE MET GLU GLY PHE TYR VAL VAL SEQRES 29 A 405 PHE ASP ARG ALA ARG LYS ARG ILE GLY PHE ALA VAL SER SEQRES 30 A 405 ALA CYS HIS VAL HIS ASP GLU PHE ARG THR ALA ALA VAL SEQRES 31 A 405 GLU GLY PRO PHE VAL THR LEU ASP MET GLU ASP CYS GLY SEQRES 32 A 405 TYR ASN HET 4QF A 501 33 HETNAM 4QF (5R,7S)-8-BENZYL-4-(CYCLOHEXYLAMINO)-1-(3- HETNAM 2 4QF FLUOROPHENYL)-7-METHYL-1,3,8-TRIAZASPIRO[4.5]DEC-3-EN- HETNAM 3 4QF 2-ONE FORMUL 2 4QF C27 H33 F N4 O FORMUL 3 HOH *277(H2 O) HELIX 1 AA1 PHE A 447 VAL A 3 5 5 HELIX 2 AA2 GLN A 53 SER A 57 5 5 HELIX 3 AA3 TYR A 123 ALA A 127 5 5 HELIX 4 AA4 PRO A 135 THR A 144 1 10 HELIX 5 AA5 ASP A 180 SER A 182 5 3 HELIX 6 AA6 ASP A 216 TYR A 222 5 7 HELIX 7 AA7 LYS A 238 SER A 252 1 15 HELIX 8 AA8 PRO A 258 LEU A 263 1 6 HELIX 9 AA9 PRO A 276 PHE A 280 5 5 HELIX 10 AB1 LEU A 301 TYR A 305 1 5 HELIX 11 AB2 GLY A 334 GLU A 339 1 6 HELIX 12 AB3 ASP A 378 GLY A 383 5 6 SHEET 1 AA1 9 ARG A 61 PRO A 70 0 SHEET 2 AA1 9 ALA A 75 SER A 86 -1 O TRP A 76 N VAL A 69 SHEET 3 AA1 9 TYR A 14 VAL A 20 -1 N THR A 19 O SER A 86 SHEET 4 AA1 9 LEU A 6 GLY A 8 -1 N ARG A 7 O TYR A 15 SHEET 5 AA1 9 VAL A 170 ILE A 176 -1 O VAL A 170 N GLY A 8 SHEET 6 AA1 9 PHE A 150 CYS A 155 -1 N GLN A 153 O SER A 173 SHEET 7 AA1 9 PHE A 341 ASP A 346 -1 O VAL A 343 N LEU A 152 SHEET 8 AA1 9 ARG A 351 SER A 357 -1 O GLY A 353 N VAL A 344 SHEET 9 AA1 9 TYR A 184 PRO A 192 -1 N THR A 191 O ILE A 352 SHEET 1 AA213 ARG A 61 PRO A 70 0 SHEET 2 AA213 ALA A 75 SER A 86 -1 O TRP A 76 N VAL A 69 SHEET 3 AA213 VAL A 95 ASP A 106 -1 O ALA A 101 N GLU A 79 SHEET 4 AA213 PHE A 38 GLY A 41 1 N VAL A 40 O ILE A 102 SHEET 5 AA213 GLY A 117 GLY A 120 -1 O ILE A 118 N ALA A 39 SHEET 6 AA213 GLN A 25 ASP A 32 1 N LEU A 30 O LEU A 119 SHEET 7 AA213 TYR A 14 VAL A 20 -1 N TYR A 14 O VAL A 31 SHEET 8 AA213 LEU A 6 GLY A 8 -1 N ARG A 7 O TYR A 15 SHEET 9 AA213 VAL A 170 ILE A 176 -1 O VAL A 170 N GLY A 8 SHEET 10 AA213 PHE A 150 CYS A 155 -1 N GLN A 153 O SER A 173 SHEET 11 AA213 PHE A 341 ASP A 346 -1 O VAL A 343 N LEU A 152 SHEET 12 AA213 ARG A 351 SER A 357 -1 O GLY A 353 N VAL A 344 SHEET 13 AA213 TYR A 184 PRO A 192 -1 N THR A 191 O ILE A 352 SHEET 1 AA3 5 GLU A 200 VAL A 201 0 SHEET 2 AA3 5 SER A 225 VAL A 227 -1 O SER A 225 N VAL A 201 SHEET 3 AA3 5 THR A 331 MET A 333 1 O MET A 333 N ILE A 226 SHEET 4 AA3 5 LEU A 234 PRO A 237 -1 N ARG A 235 O VAL A 332 SHEET 5 AA3 5 ILE A 324 SER A 327 1 O SER A 325 N LEU A 236 SHEET 1 AA4 5 GLN A 211 ASP A 212 0 SHEET 2 AA4 5 ILE A 203 ILE A 208 -1 N ILE A 208 O GLN A 211 SHEET 3 AA4 5 ILE A 283 MET A 288 -1 O TYR A 286 N ARG A 205 SHEET 4 AA4 5 GLN A 294 ILE A 300 -1 O ILE A 300 N ILE A 283 SHEET 5 AA4 5 ALA A 369 VAL A 375 -1 O GLU A 371 N ARG A 297 SHEET 1 AA5 3 VAL A 268 GLN A 271 0 SHEET 2 AA5 3 ASP A 317 PHE A 322 -1 O ASP A 318 N TRP A 270 SHEET 3 AA5 3 LEU A 306 PRO A 308 -1 N ARG A 307 O LYS A 321 SSBOND 1 CYS A 155 CYS A 359 1555 1555 2.05 SSBOND 2 CYS A 217 CYS A 382 1555 1555 2.04 SSBOND 3 CYS A 269 CYS A 319 1555 1555 2.03 CISPEP 1 SER A 22 PRO A 23 0 -0.12 CISPEP 2 ARG A 128 PRO A 129 0 3.99 CISPEP 3 TYR A 222 ASP A 223 0 1.83 CISPEP 4 GLY A 372 PRO A 373 0 -6.78 SITE 1 AC1 17 ASP A 32 TYR A 71 THR A 72 GLN A 73 SITE 2 AC1 17 GLY A 74 LYS A 107 PHE A 108 ILE A 110 SITE 3 AC1 17 TRP A 115 TYR A 198 GLY A 230 THR A 231 SITE 4 AC1 17 THR A 329 HOH A 603 HOH A 652 HOH A 773 SITE 5 AC1 17 HOH A 797 CRYST1 103.830 127.680 77.070 90.00 90.00 90.00 C 2 2 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009631 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007832 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012975 0.00000 MASTER 317 0 1 12 35 0 5 6 0 0 0 32 END